반응식
C[CH:2]([CH:6]([OH:9])[CH2:7][Cl:8])[CH2:3][CH2:4][OH:5].Cl[C:11]1[CH:12]=[C:13]([CH2:19][OH:20])[C:14]([CH2:17][OH:18])=[CH:15][CH:16]=1>>[Cl:8][CH2:7][CH:6]([OH:9])[CH2:2][CH2:3][CH2:4][OH:5].[C:13]1([CH2:19][OH:20])[C:14]([CH2:17][OH:18])=[CH:15][CH:16]=[CH:11][CH:12]=1참가 물질
4
실험 절차
Example 8 was repeated except for using 20.9 g (137 mmoles) of 3-methyl-5-chloro-1,4-pentanediol and 4.94 g (28.6 mmoles) of 4-chloro-o-xylylene glycol, instead of 19.0 g (137 mmoles) of 5-chloro-1,4-pentanediol and 3.95 g (28.6 mmoles) of o-xylylene glycol, respectively, to obtain spiro[7-chloro-1,5-dihydro-2,4-benzodioxepin-4'-methylene-5'-methyl-3,2'-[1,3]dioxepane].
출처 및 근거
- ORD 기록
- ord-dbb789fdbf02448bb80bd265e0933b4e
- 출처 데이터셋
- uspto-grants-1994_03
- 특허 번호
- US05298631
연결된 노트
불러오는 중…